Skip to main content
logo
Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
36.08
+0.75 (2.12%)
At close: Oct 31, 2025, 4:00 PM EDT
36.91
+0.83 (2.30%)
After-hours: Oct 31, 2025, 6:12 PM EDT

Veracyte Revenue

Veracyte had revenue of $130.16M in the quarter ending June 30, 2025, with 13.75% growth. This brings the company's revenue in the last twelve months to $479.13M, up 19.91% year-over-year. In the year 2024, Veracyte had annual revenue of $445.76M with 23.46% growth.

Revenue (ttm)
$479.13M
Revenue Growth
+19.91%
P/S Ratio
5.86
Revenue / Employee
$581,467
Employees
824
Market Cap
2.84B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024445.76M84.71M23.46%
Dec 31, 2023361.05M64.52M21.76%
Dec 31, 2022296.54M77.02M35.09%
Dec 31, 2021219.51M102.03M86.85%
Dec 31, 2020117.48M-2.89M-2.40%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings

VCYT News

More News